en.unionpedia.org

Biolex, the Glossary

Index Biolex

Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors.[1]

Table of Contents

  1. 20 relations: B cell, Biotechnology, CD20, Chapter 7, Title 11, United States Code, France, Glycosylation, Interferon, Lemna, Lemnoideae, Medication, Monoclonal antibody, Netherlands, Non-Hodgkin lymphoma, Plantibody, Polaris Partners, Preclinical development, Recombinant DNA, Research Triangle Park, Synthon (company), Thrombolysis.

  2. 1997 establishments in North Carolina
  3. 2012 disestablishments in North Carolina
  4. Biotechnology companies disestablished in 2012
  5. Biotechnology companies established in 1997
  6. Pharmaceutical companies disestablished in 2012

B cell

B cells, also known as B lymphocytes, are a type of white blood cell of the lymphocyte subtype.

See Biolex and B cell

Biotechnology

Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services. Biolex and Biotechnology are Life sciences industry.

See Biolex and Biotechnology

CD20

B-lymphocyte antigen CD20 or CD20 is B lymphocyte cell-surface molecule.

See Biolex and CD20

Chapter 7, Title 11, United States Code

Chapter 7 of Title 11 U.S. Code is the bankruptcy code that governs the process of liquidation under the bankruptcy laws of the U.S. In contrast to bankruptcy under Chapter 11 and Chapter 13, which govern the process of reorganization of a debtor, Chapter 7 bankruptcy is the most common form of bankruptcy in the U.S.

See Biolex and Chapter 7, Title 11, United States Code

France

France, officially the French Republic, is a country located primarily in Western Europe.

See Biolex and France

Glycosylation

Glycosylation is the reaction in which a carbohydrate (or 'glycan'), i.e. a glycosyl donor, is attached to a hydroxyl or other functional group of another molecule (a glycosyl acceptor) in order to form a glycoconjugate.

See Biolex and Glycosylation

Interferon

Interferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several viruses.

See Biolex and Interferon

Lemna

Lemna is a genus of free-floating aquatic plants referred to by the common name "duckweed".

See Biolex and Lemna

Lemnoideae

Lemnoideae is a subfamily of flowering aquatic plants, known as duckweeds, water lentils, or water lenses.

See Biolex and Lemnoideae

Medication

A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.

See Biolex and Medication

Monoclonal antibody

A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell.

See Biolex and Monoclonal antibody

Netherlands

The Netherlands, informally Holland, is a country located in Northwestern Europe with overseas territories in the Caribbean.

See Biolex and Netherlands

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma (NHL), also known as non-Hodgkin's lymphoma, is a group of blood cancers that includes all types of lymphomas except Hodgkin lymphomas.

See Biolex and Non-Hodgkin lymphoma

Plantibody

Passive immunization is a medical strategy long employed to provide temporary protection against pathogens.

See Biolex and Plantibody

Polaris Partners

Polaris Partners is a venture capital firm active in the field of healthcare and biotechnology companies. Biolex and Polaris Partners are Life sciences industry.

See Biolex and Polaris Partners

Preclinical development

In drug development, preclinical development (also termed preclinical studies or nonclinical studies) is a stage of research that begins before clinical trials (testing in humans) and during which important feasibility, iterative testing and drug safety data are collected, typically in laboratory animals.

See Biolex and Preclinical development

Recombinant DNA

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination (such as molecular cloning) that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

See Biolex and Recombinant DNA

Research Triangle Park

Research Triangle Park (RTP) is the largest research park in the United States, occupying in North Carolina and hosting more than 300 companies and 65,000 workers.

See Biolex and Research Triangle Park

Synthon (company)

Synthon is a Dutch multinational that produces generic human drugs. Biolex and Synthon (company) are Life sciences industry.

See Biolex and Synthon (company)

Thrombolysis

Thrombolysis, also called fibrinolytic therapy, is the breakdown (lysis) of blood clots formed in blood vessels, using medication.

See Biolex and Thrombolysis

See also

1997 establishments in North Carolina

2012 disestablishments in North Carolina

Biotechnology companies disestablished in 2012

  • Biolex

Biotechnology companies established in 1997

Pharmaceutical companies disestablished in 2012

References

[1] https://en.wikipedia.org/wiki/Biolex

Also known as Epicyte, Epicyte Pharmaceutical, Epicyte Pharmaceutical Inc..